İstanbul Üniversitesi
Akademik Veri Yönetim Sistemi

Araştırmacı kurumdan ayrılmıştır.

Yayınlar & Eserler
SCI,SSCI,AHCI İNDEKSLERİNE GİREN DERGİLERDE YAYINLANAN MAKALELER
Haydar S., Paillot T., Cogne Y., Fountas A., Tütüncü Y., Vintila M., et al., "Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations", NUTRIENTS, vol.10, pp.1392-1392, 2018
Gürol A.O., Okten-Kursun A., Kasapoglu P., Suzergoz F., Küçüksezer U.C., Çevik A., et al.,"The synergistic effect of omega 3 and Vit D3 on glycemia and TNF-alpha in islet transplantation", CELLULAR AND MOLECULAR BIOLOGY, vol.62, pp.90-98, 2016
Tütüncü Y., Satman İ., Çelik S., Dinççağ N., Karşidağ K., Telci A., et al., "A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria", JOURNAL OF DIABETES RESEARCH, 2016
Uzum A.K., Aydin M.M., Tütüncü Y., Ömer B., Kiyan E., Alagol F., "Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.", EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol.25, pp.364-369, 2014
Satman İ., Ömer B., Tütüncü Y., Kalaca S., Gedik S., Dinççağ N., et al., "Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults", EUROPEAN JOURNAL OF EPIDEMIOLOGY, vol.28, pp.169-180, 2013 (Link)
Kocabay G., Telci A., Tütüncü Y., Tiryaki B., Ozel S., Cevikbas U., et al.,"Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?", BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, vol.112, pp.626-629, 2011
Can A., Bekpinar S., Gürdöl F., Tütüncü Y., Unlucerci Y., Dinççağ N., "Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control", DIABETES RESEARCH AND CLINICAL PRACTICE, vol.94, pp.E61-E64, 2011
Kocabay G., Telci A., Tütüncü Y., Tiryaki B., Oezel S., Cevikba U., et al., "SERUM HS-CRP LEVELS DO NOT INDICATE THE SEVERITY OF LIVER DAMAGE IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH TYPE-2 DIABETES MELLITUS", NOBEL MEDICUS, vol.6, pp.43-46, 2010
Kocabay G., Telci A., Tütüncü Y., Tiryaki B., Oezel S., Cevikba U., et al.,"SERUM HS-CRP LEVELS DO NOT INDICATE THE SEVERITY OF LIVER DAMAGE IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH TYPE-2 DIABETES MELLITUS", NOBEL MEDICUS, vol.6, pp.43-46, 2010
Kocabay G., Tütüncü Y., Yilmaz H., Demir K., "Impact of apolipoprotein E genotypes on phenotypic expression in Turkish patients with Wilson's disease", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, vol.44, pp.1270-1271, 2009
Oezguel R.K., Satman I., Collin G.B., Hinman E.G., Marshall J.D., Kocaman O., et al., "Molecular analysis and long-term clinical evaluation of three siblings with Alstrom syndrome", CLINICAL GENETICS, vol.72, pp.351-356, 2007
Yilmaz V., Tütüncü Y., Hasbal N.B., Parman F.Y., Serdaroglu P., Deymeer F., et al.,"Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis", HUMAN IMMUNOLOGY, vol.68, pp.544-549, 2007
Dream Trial Investigators .., Dinççağ N., Tütüncü Y., "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial", LANCET, vol.368, pp.1096-1105, 2006
Yildiz A., Tütüncü Y., Yazici H., Akkaya V., Kayacan S.M., Sever M.Ş., et al., "Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients", TRANSPLANTATION, vol.74, pp.1109-1113, 2002
Satman İ., Satman İ., Yilmaz M.T., Sengül A., Salman S., Salman F., et al., "Population-based study of diabetes and risk characteristics in Turkey: Results of the Turkish Diabetes Epidemiology Study (TURDEP)", DIABETES CARE, vol.25, pp.1551-1556, 2002
Yildiz P., Kadakal F., Tütüncü Y., Deniz G., Polat N.G., Çinar S., et al., "Natural killer cell activity in multidrug-resistant pulmonary tuberculosis", RESPIRATION, vol.68, pp.590-594, 2001
DİĞER DERGİLERDE YAYINLANAN MAKALELER
Kanca Demirci D., Gül N., Tütüncü Y., Öztürk O., Satman İ., Yilmaz Aydoğan H., "MODY3 Hastalarında HNF1A Geni rs1169288 (A>C) Mutasyonunun Etkilerinin Araştırılması", Haliç Üniversitesi Fen Bilimleri Dergisi , cilt.1, ss.21-32, 2018
Tuncer F.N., Tütüncü Y., Yarman E.S., "SPORADİK MEDU¨LLER TİROİD KANSERLİ BİR HASTADA NADİR GO¨RU¨LEN RET PROTO-ONKOGEN MUTASYONU: D631Y", Deneysel Tıp Dergisi, cilt.7, ss.101-107, 2017
Dinççağ N., Çelik S., İdiz C., Tütüncü Y., Özel Yildiz S., Satman İ., "Awareness of Diabetes and Obesity in Turkey", Turkish Journal of Endocrinology and Metabolism, vol.21, pp.31-36, 2017
Tütüncü Y., Satman İ., Çelik S., Canbaz B., Turker F., Dinççağ N., et al., "THE IMPACT OF hsCRP LEVELS ACROSS GLUCOSE TOLERANCE CATEGORIES: FROM NORMAL GLUCOSE TOLERANCE TO ESTABLISHED DIABETES", NOBEL MEDICUS, vol.12, pp.38-44, 2016 (Group Author(s): TURDEP-II Study Grp )
Cabioğlu N., Müslümanoğlu M.E., Tütüncü Y., Çinar S., Polat N.G., Kiran B., et al., "Immune changes in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy", Turkish Journal of Immunology, vol.13, pp.15-20, 2008
HAKEMLİ KONGRE / SEMPOZYUMLARIN BİLDİRİ KİTAPLARINDA YER ALAN YAYINLAR
Diren A., Kanca Demirci D., Gül N., Karacanli B., Baykut A., Tütüncü Y., et al.,"Th17-related Cytokine Panel: Can We Use It As A Potential Biomarker In Differential Diagnosis Of Mody? ", 100th Annual Meeting of the Endocrine Society, Chicago, ABD, 17-20 Mart 2018, pp.169-169
Kural F. , İdiz C., Tütüncü Y., Ozer E., Satman İ., "Predictive value of CRP, ADMA and visfatin during diabetes prevention with lifestyle intervention", 70th Annual Meeting of the American Diabetes Association (ADA), Orlando, ABD, 25-29 Haziran 2010, vol.59, no.1, pp.A673-A673
Akademik Veri Yönetim Sistemi | All Rights Reserved | Abis Teknoloji © 2019
İstanbul Üniversitesi BAP Koordinasyon Birimi